Clinical Features and Long-Term Outcomes of Patients Diagnosed with MASLD, MAFLD, or Both

We read with great interest the recently reported work regarding clinical profiles for metabolic dysfunction-associated steatotic liver disease (MASLD) and non-alcoholic fatty liver disease (NAFLD) by Younossi 1. Metabolic dysfunction-associated fatty liver disease (MAFLD) and MASLD were introduced as new terminologies to address the limitations associated with NAFLD 2,3. MASLD encompasses patients with at least one of five cardiometabolic risk factors and captures more lean patients than MAFLD.

Source: Journal of Hepatology - March 28, 2024 Category: Gastroenterology Authors: Xiao-Dong Zhou, Amedeo Lonardo, Calvin Q. Pan, Michael D. Shapiro, Ming-Hua Zheng, WMU MAFLD Clinical Research Working Group Tags: Letter to the Editor Source Type: research